UPDATE 1-Merck's Keytruda fails pivotal gastric cancer trial
December 14, 2017 at 17:38 PM EST
Dec 14 (Reuters) - Merck & Co Inc said on Thursday a key late-stage trial testing its blockbuster drug, Keytruda, failed to meet its main goal of extending lives of patients with a type of gastric cancer.
